Lista de obras - Avidan Neumann - Dominio Público Uruguay

A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients

artículo científico publicado en 2006

A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients

artículo científico publicado en 2015

Age dependent differences in the kinetics of γδ T cells after influenza vaccination

artículo científico publicado en 2017

Antiviral action of ribavirin in chronic hepatitis C.

artículo científico publicado en 2004

Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication

artículo científico publicado en 2002

Combining longitudinal discriminant analysis and partial area under the ROC curve to predict non-response to treatment for hepatitis C virus

artículo científico publicado en 2010

Correction: Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection

artículo científico publicado en 2017

Design evaluation and optimization for models of hepatitis C viral dynamics.

artículo científico publicado en 2011

Differential immune response against two BK virus antigens explains control of BK viremia post-kidney transplant

scholarly article by Arturo Blázquez-Navarro published in May 2016

Differential influenza H1N1-specific humoral and cellular response kinetics in kidney transplant patients.

artículo científico publicado en 2013

Early prediction of sustained virological response at day 3 of treatment with albinterferon-alpha-2b in patients with genotype 2/3 chronic hepatitis C.

artículo científico publicado en 2009

Effects of aging on human leukocytes (part I): immunophenotyping of innate immune cells

artículo científico publicado en 2015

Effects of aging on human leukocytes (part II): immunophenotyping of adaptive immune B and T cell subsets

scientific article published on 02 September 2015

Erratum to: Effects of aging on human leukocytes (part II): immunophenotyping of adaptive immune B and T cell subsets

artículo científico publicado en 2016

HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project).

artículo científico publicado en 2007

Hepatitis B viral kinetics: a dynamic puzzle still to be resolved

artículo científico publicado en 2005

Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity.

artículo científico publicado en 2007

Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-alpha2a/ribavirin therapy

artículo científico publicado en 2008

Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees

artículo científico publicado en 2004

Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation.

artículo científico publicado en 2011

IMSEQ--a fast and error aware approach to immunogenetic sequence analysis

artículo científico publicado en 2015

IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection

artículo científico publicado en 2006

Impact of disease severity on outcome of antiviral therapy in treatment-naïve patients with chronic hepatitis C.

artículo científico publicado en 2007

Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection

artículo científico publicado en 2013

In vivo dynamical interactions between CD4 Tregs, CD8 Tregs and CD4+ CD25- cells in mice

artículo científico publicado en 2009

Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection

artículo científico publicado en 2006

International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C.

artículo científico publicado en 2005

Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice

artículo científico publicado en 2014

Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study

artículo científico publicado en 2012

Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production

artículo científico publicado en 2005

Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection

artículo científico publicado en 2017

Novel mechanism of antibodies to hepatitis B virus in blocking viral particle release from cells.

artículo científico publicado en 2010

Pegylated interferon and ribavirin promote early evolution of nonstructural 5A protein in individuals with hepatitis C who demonstrate a response to treatment

artículo científico publicado en 2009

Pharmacodynamics of PEG-IFN-alpha-2a in HIV/HCV co-infected patients: implications for treatment outcomes

artículo científico publicado en 2010

Pharmacodynamics of PEG-IFN-α-2a and HCV Response as a Function of IL28B Polymorphism in HIV/HCV-Coinfected Patients ⬇️

artículo científico publicado el 1 de febrero de 2011

Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naïve patients with genotype 1, chronic hepatitis C.

artículo científico publicado en 2009

Predicting treatment outcome following 24 weeks peginterferon alpha-2a/ribavirin therapy in patients infected with HCV genotype 1: utility of HCV-RNA at day 0, day 22, day 29, and week 6.

artículo científico publicado en 2007

Rapid decrease of wild-type hepatitis C virus on telaprevir treatment.

artículo científico publicado en 2009

Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms

artículo científico publicado en 2011

Ribavirin improves early responses to peginterferon through improved interferon signaling

artículo científico publicado en 2010

Second hepatitis C replication compartment indicated by viral dynamics during liver transplantation.

artículo científico publicado en 2005

Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C

artículo científico publicado en 2010

The extrahepatic contribution to HCV plasma viremia

artículo científico publicado en 2006

The genetic predisposition of natural killer cell to BK virus-associated nephropathy in renal transplant patients

artículo científico publicado en 2013

Therapeutic response to peg-IFN-alpha-2b and ribavirin in HIV/HCV co-infected African-American and Caucasian patients as a function of HCV viral kinetics and interferon pharmacodynamics

artículo científico publicado en 2009

Virus dynamics and immune responses during treatment in patients coinfected with hepatitis C and HIV.

artículo científico publicado en 2004

Lista de obras de Avidan Neumann

A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients

A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients

Age dependent differences in the kinetics of γδ T cells after influenza vaccination

Antiviral action of ribavirin in chronic hepatitis C.

Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication

Combining longitudinal discriminant analysis and partial area under the ROC curve to predict non-response to treatment for hepatitis C virus

Correction: Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection

Design evaluation and optimization for models of hepatitis C viral dynamics.

Differential immune response against two BK virus antigens explains control of BK viremia post-kidney transplant

Differential influenza H1N1-specific humoral and cellular response kinetics in kidney transplant patients.

Early prediction of sustained virological response at day 3 of treatment with albinterferon-alpha-2b in patients with genotype 2/3 chronic hepatitis C.

Effects of aging on human leukocytes (part I): immunophenotyping of innate immune cells

Effects of aging on human leukocytes (part II): immunophenotyping of adaptive immune B and T cell subsets

Erratum to: Effects of aging on human leukocytes (part II): immunophenotyping of adaptive immune B and T cell subsets

HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project).

Hepatitis B viral kinetics: a dynamic puzzle still to be resolved

Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity.

Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-alpha2a/ribavirin therapy

Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees

Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation.

IMSEQ--a fast and error aware approach to immunogenetic sequence analysis

IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection

Impact of disease severity on outcome of antiviral therapy in treatment-naïve patients with chronic hepatitis C.

Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection

In vivo dynamical interactions between CD4 Tregs, CD8 Tregs and CD4+ CD25- cells in mice

Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection

International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C.

Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice

Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study

Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production

Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection

Novel mechanism of antibodies to hepatitis B virus in blocking viral particle release from cells.

Pegylated interferon and ribavirin promote early evolution of nonstructural 5A protein in individuals with hepatitis C who demonstrate a response to treatment

Pharmacodynamics of PEG-IFN-alpha-2a in HIV/HCV co-infected patients: implications for treatment outcomes

Pharmacodynamics of PEG-IFN-α-2a and HCV Response as a Function of IL28B Polymorphism in HIV/HCV-Coinfected Patients ⬇️

Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naïve patients with genotype 1, chronic hepatitis C.

Predicting treatment outcome following 24 weeks peginterferon alpha-2a/ribavirin therapy in patients infected with HCV genotype 1: utility of HCV-RNA at day 0, day 22, day 29, and week 6.

Rapid decrease of wild-type hepatitis C virus on telaprevir treatment.

Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms

Ribavirin improves early responses to peginterferon through improved interferon signaling

Second hepatitis C replication compartment indicated by viral dynamics during liver transplantation.

Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C

The extrahepatic contribution to HCV plasma viremia

The genetic predisposition of natural killer cell to BK virus-associated nephropathy in renal transplant patients

Therapeutic response to peg-IFN-alpha-2b and ribavirin in HIV/HCV co-infected African-American and Caucasian patients as a function of HCV viral kinetics and interferon pharmacodynamics

Virus dynamics and immune responses during treatment in patients coinfected with hepatitis C and HIV.